Wing Venture Capital and Insight Partners led a $50m Series B round in Chemify.

Wing Venture Capital, an AI-driven business investor, focusing on Seed and Series A stages, and Insight Partners, a global technology and software investor, led a $50m Series B round in Chemify with participation from 8VC, Triatomic Capital, Blueyard, Rockspring and Eos. “Chemify's technology uses automation and physical AI to enable the digitization of chemistry, transforming chemical synthesis from an art to a programmable science. We are excited to support the team’s progress as they empower scientists to create novel molecules with unmatched efficiency and precision. Their work has the potential to drive significant advancements in drug discovery and medicine," Ansuman Satpathy, Wing Venture Capital Partner.